Henry Schein insider trading
Health Care · Net sellingShare price and insider trades
Valuation, profit and volume
Summary
Over the past 12 months, 1 Henry Schein insider reported open-market purchases totaling $692K, while 5 insiders reported sales totaling $8.6M. 0 of 10 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales. 61 grants, option exercises and tax withholdings are not shown.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| May 12SEC | William K DanielDirector | Buy | 10,000 | $69.19 | $692K | +21.7% | — |
| Mar 20SEC | Thomas C PopeckCEO | Sell | 1,355 | $72.79 | $99K | +15.7% | — |
| Mar 11SEC | Kurt P KuehnDirector | Sell | 2,844 | $78.96 | $225K | +6.7% | — |
| Mar 6SEC | Mark E MlotekEvp, Chief Strategic Officer | Sell | 4,100 | $80.80 | $331K | +4.3% | — |
| Mar 6SEC | Philip A LaskawyDirector | Sell | 2,844 | $80.36 | $229K | +4.8% | — |
| Mar 6SEC | Mark E MlotekEvp, Chief Strategic Officer | Sell | 1,825 | $80.81 | $147K | +4.2% | — |
| Mar 3SEC | Stanley M BergmanCEO, Chair | Sell | 23,858 | $81.31 | $1.9M | +3.6% | — |
| Mar 3SEC | Stanley M BergmanCEO, Chair | Sell | 19,954 | $81.31 | $1.6M | +3.6% | — |
| Feb 27SEC | Stanley M BergmanCEO, Chair | Sell | 31,134 | $80.90 | $2.5M | +4.1% | — |
| Feb 27SEC | Stanley M BergmanCEO, Chair | Sell | 10,785 | $81.20 | $876K | +3.7% | — |
| Feb 27SEC | Stanley M BergmanCEO, Chair | Sell | 7,212 | $81.51 | $588K | +3.3% | — |
Insiders at Henry Schein
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Stanley M BergmanFormer Director | — | $7.5M | May 26, 2026 | — |
| William K DanielDirector | $692K | — | Jun 15, 2026 | — |
| Mark E MlotekEvp, Chief Strategic Officer | — | $479K | Mar 17, 2026 | — |
| Philip A LaskawyDirector | — | $229K | Mar 9, 2026 | — |
| Kurt P KuehnDirector | — | $225K | Mar 11, 2026 | — |
| Thomas C PopeckCEO | — | $99K | Mar 20, 2026 | — |
| Andrea AlbertiniCEO | — | — | Sep 9, 2026 | — |
| Ronald N. SouthCFO | — | — | Mar 17, 2026 | — |
| Michael S EttingerCOO | — | — | Mar 17, 2026 | — |
| Christine Zayac SheehySvp, Chief Human Res. Officer | — | — | Mar 17, 2026 | — |
| Frederick M. LoweryCEO | — | — | Mar 10, 2026 | — |
| Bradley T ShearesDirector | — | — | Mar 9, 2026 | — |
| Joseph L HerringDirector | — | — | Mar 9, 2026 | — |
| Deborah DerbyDirector | — | — | Mar 9, 2026 | — |
| Robert J. HombachDirector | — | — | Mar 9, 2026 | — |
| Reed Vaughn TucksonDirector | — | — | Mar 9, 2026 | — |
| Mohamad AliDirector | — | — | Mar 9, 2026 | — |
| Anne H. MarguliesDirector | — | — | Mar 9, 2026 | — |
| Carole T FaigDirector | — | — | Mar 9, 2026 | — |
| Scott Philip SerotaDirector | — | — | Mar 9, 2026 | — |
Insider activity at other Health Care companies
Same sector, ranked by insider buying in the last 90 days.
Common questions about HSIC insiders
Are Henry Schein insiders buying HSIC stock?
In the past 12 months, 1 insiders reported open-market purchases of HSIC worth $692K. The latest was Director William K Daniel bought $692K of HSIC at $69.19 — first open-market purchase in our records; raises the stake by 100%.
Are Henry Schein insiders selling HSIC stock?
5 insiders reported sales worth $8.6M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.